Company Profiles

driven by the PitchBook Platform

Adello Biologics

Adello Biologics
2003 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$8.4M LATEST DEAL AMOUNT
$8.5M TOTAL AMOUNT RAISED
Description

Developer of bio-pharmaceutical products. The company manufactures bio-similar recombinant therapeutic proteins. Its products include small-dose cytokines, large-dose monoclonal antibodies and fusion proteins.

Formerly Known As
Therapeutic Proteins
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
3440 South Dearborn Street
Suite 300
Chicago, IL 60616
United States

+1 (312) 620-1500
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adello Biologics’s full profile, request a free trial.

Adello Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 28-Jul-2010 $8.4M $8.5M Completed Generating Revenue
1. Early Stage VC 01-Jul-2005 000 000 Completed Product Development
To view this company’s complete deal history including valuation and funding request access »

Adello Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Capital Midwest Fund Venture Capital Minority 000 0000 000000 0
Tarsadia Investments PE/Buyout Minority 000 0000 000000 0

You’re viewing 2 of 2 investors.

Adello Biologics Executive Team (6)

Name Title Board
Seat
Contact
Info
Peter Moesta Ph.D Chief Executive Officer
Michael Washabaugh Chief Scientific Officer
Ali Niazi Director
Sarfaraz Niazi Ph.D Founder & Executive Chairman
Sunitha Lakshminarayanan Senior Director, Process Development
You’re viewing 5 of 6 executives. Get the full list »

Adello Biologics Board Members (1)

Name Representing Role Since Contact
Info
Sarfaraz Niazi Ph.D Adello Biologics Founder & Executive Chairman 000 0000

You’re viewing 1 of 1 board members.